Liver cancer trial: Dr Toh Han Chong on ongoing study using Atezolizumab plus Bevacizumab to lower recurrence risk in patients with hepatocellular carcinoma
He leads a Phase III, randomised, open-label study of Atezolizumab plus Bevacizumab versus active surveillance as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after surgical resection or ablation.
Breast cancer trial: Dr Yap Yoon Sim on why ongoing clinical trial is significant for patients with PIK3CA-mutant, hormone receptor-positive, Her2-negative, locally advanced or metastatic breast cancer
The phase III, randomised, double-blind, placebo-controlled study evaluates the efficacy and safety of GDC-0077 plus palbociclib and fulvestrant versus placebo plus palbociclib and fulvestrant in patients who meet the specific trial criteria.
Oncoshot wins at Technode Global Origin Innovation Awards 2020
Oncoshot won in the Healthtech category of the Startup Awards, which honour regional startups that embody the spirit of innovation and entrepreneurship.
Oncoshot introduces new cancer clinical trial notification service
The free service is designed to help busy oncologists identify promising cancer clinical trials for their patients in an efficient manner.
What are clinical trials and just how important are they in cancer care?
With cancer continuing to be a leading cause of mortality worldwide, cutting-edge cancer clinical trials can help you expand your treatment options.
Breast cancer: know your screening and treatment options
In light of Breast Cancer Awareness month in October, we highlight potentially live-saving detection methods and new therapies - including those you may access through clinical trials.